AZTA
What one share of Azenta holds
Special Industry Machinery, NEC
We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market.
Azenta’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $13.41 |
|---|---|
| Profit | −$2.68 |
| Capex (buildings and equipment) | $0.61 |
| Free cash flow | $0.22 |
| Cash and investments | $4.33 |
| Book value | $34.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.48 | −$3.62 | $0.18 | −$1.08 | — | $5.05 |
| 2010 | $9.24 | $0.93 | $0.05 | $0.38 | — | $5.94 |
| 2011 | $10.59 | $2.01 | $0.10 | $1.25 | $0.08 | $7.82 |
| 2012 | $7.44 | $2.08 | $0.13 | $0.42 | $0.32 | $9.78 |
| 2013 | $6.41 | −$0.03 | $0.06 | $0.77 | $0.32 | $9.49 |
| 2014 | $7.14 | $0.46 | $0.08 | $0.71 | $0.34 | $9.61 |
| 2015 | $8.06 | $0.21 | $0.24 | $0.40 | $0.40 | $9.35 |
| 2016 | $6.34 | −$1.01 | $0.19 | $0.39 | $0.40 | $8.05 |
| 2017 | $7.48 | $0.89 | $0.18 | $1.19 | $0.40 | $8.70 |
| 2018 | $8.90 | $1.64 | $0.18 | $0.86 | $0.40 | $10.15 |
| 2019 | $4.62 | $6.04 | $0.33 | $0.93 | $0.40 | $15.75 |
| 2020 | $5.26 | $0.88 | $0.54 | −$0.03 | $0.40 | $16.44 |
| 2021 | $6.90 | $1.49 | $0.71 | $1.30 | $0.40 | $17.83 |
| 2022 | $7.42 | $28.48 | $0.98 | −$7.20 | $0.10 | $44.83 |
| 2023 | $8.32 | −$0.22 | $0.60 | −$0.51 | — | $43.82 |
| 2024 | $10.78 | −$3.10 | $0.70 | $0.23 | — | $38.79 |
| 2025 | $12.94 | −$1.22 | $0.74 | $0.83 | — | $37.66 |